Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 840M | 656M | 625M | 594M | 645M | 613M |
| Cost of revenue | 517M | 379M | 359M | 343M | 378M | 346M |
| Gross profit | 323M | 277M | 266M | 251M | 268M | 267M |
| Research and development | 20M | 18M | 16M | 16M | 15M | 16M |
| Selling, general and administrative | 191M | 158M | 156M | 157M | 158M | 155M |
| Operating expenses | 211M | 176M | 172M | 173M | 173M | 171M |
| Operating income | 111M | 101M | 94M | 77M | 95M | 96M |
| Pre-tax income | 83M | 56M | 63M | 116M | 77M | 74M |
| Income tax | 27M | 16M | 16M | 18M | 37M | −18M |
| Net income | 56M | 39M | 47M | 98M | 40M | 93M |
| Earnings per share | 0.23 | 0.16 | 0.20 | 0.40 | 0.17 | 0.39 |
| Earnings per share, diluted | 0.23 | 0.16 | 0.20 | 0.40 | 0.17 | 0.39 |
| Weighted average shares | 243M | 242M | 242M | 242M | 242M | 242M |
| Weighted average shares, diluted | 244M | 242M | 242M | 243M | 243M | 243M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 177M | 627M | 594M | 530M | 499M | 359M | 376M | 309M |
| Receivables | 677M | 518M | 502M |
| Metric | 31 Mar 2026 | 31 Mar 2025 |
|---|---|---|
| Operating cash flow | −67M | 26M |
| Depreciation and amortisation | 43M | 37M |
| Share-based compensation | 8M | 5M |
| Capital expenditure | 25M | 11M |
| Investing cash flow | −889M | 338M |
| Dividends paid | 20M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 497M |
| 455M |
| 440M |
| 475M |
| 481M |
| Inventory | 422M | 295M | 291M | 284M | 270M | 246M | 286M | 335M |
| Current assets | 1.46B | 1.58B | 1.53B | 1.45B | 1.36B | 1.27B | 1.35B | 1.30B |
| Property, plant and equipment | 403M | 320M | 300M | 297M | 284M | 277M | 274M | 298M |
| Goodwill | 2.54B | 2.24B | 2.23B | 2.24B | 2.16B | 2.13B | 2.22B | 2.29B |
| Total assets | 5.74B | 5.10B | 5.05B | 5.00B | 4.79B | 4.87B | 5.10B | 4.98B |
| Current liabilities | 544M | 430M | 377M | 355M | 345M | 380M | 384M | 372M |
| Long-term debt | 2.06B | 1.63B | 1.63B | 1.62B | 1.62B | 1.81B | 1.91B | 1.92B |
| Total liabilities | 2.99B | 2.41B | 2.38B | 2.36B | 2.26B | 2.48B | 2.64B | 2.59B |
| Equity | 2.74B | 2.67B | 2.65B | 2.64B | 2.54B | 2.38B | 2.45B | 2.39B |
| Shares outstanding | — | 270M | 268M | 268M | 268M | 267M | 267M | 267M |
| Shares issued | 271M | 270M | 268M | 268M | 268M | 267M | 267M | 267M |
| Treasury shares | 27M | 27M | 26M | 26M | 25M | 25M | 25M | 25M |
| 20M |
| Financing cash flow | 508M | −227M |